Antibiotic Therapies for Multidrug-Resistant Infections
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 30 April 2026 | Viewed by 10
Special Issue Editor
Interests: emerging multidrug-resistant bacteria; infection control; new antibiotics for MDR infections
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The rapid emergence and global spread of multidrug-resistant (MDR) pathogens represent one of the most urgent threats to public health. Traditional antibiotics are increasingly failing against critical-priority bacteria, and the development of new therapeutic options has not kept pace with the rise in resistance.
This Special Issue of Antibiotics (IF 4.6) aims to gather high-quality original research articles, reviews, and clinical case reports addressing innovative strategies to combat MDR infections. Topics of interest include, but are not limited to, novel antimicrobial agents, optimized antibiotic combinations, pharmacokinetic and pharmacodynamic advances, alternative and adjunctive therapies, antimicrobial stewardship interventions, and translational research bridging bench to bedside.
By bringing together cutting-edge findings from basic science, clinical trials, and real-world practice, we hope to foster a deeper understanding of effective MDR management and inspire new approaches to preserve the efficacy of our antimicrobial arsenal. We invite contributions from researchers and clinicians worldwide to advance the fight against these challenging infections.
Dr. Antonio Riccardo Buonomo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- MDR
- gram-negative infections
- acinteobacter baumannii
- stenotrophomonas maltophilia
- KPC
- MBL
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
